Physician profile
Clyde A Meeks
NPI 1376639377
$1,055.72
in general payments reported to CMS, 2019-2025
19 companies · $55.15 in 2025
The $55.15 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $216 · 2020: $264 · 2021: $461 · 2022: $59.21 · 2025: $55.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $55.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $55.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $370.44 | 2020-2022 | |
| Allergan, INC. | $209.35 | 2019-2022 | |
| Hologic Sales and Service, LLC | $77.94 | 2021 | |
| Daiichi Sankyo INC. | $52.99 | 2019-2021 | |
| Coopersurgical, INC. | $44.85 | 2021 | |
| Revance Therapeutics, INC. | $40.61 | 2025 | Daxxify |
| Astellas Pharma US INC | $38.57 | 2019 | |
| Conmed Corporation | $32.58 | 2020 | |
| Therapeuticsmd, INC. | $29.53 | 2020-2022 | |
| Lupin INC. | $27.24 | 2019 | |
| Amgen INC. | $26.95 | 2021 | |
| Merck Sharp & Dohme LLC | $16.08 | 2021 | |
| Baxter Healthcare | $14.54 | 2025 | Perclot |
| Avion Pharmaceuticals | $14.03 | 2021 | |
| Novo Nordisk INC | $13.96 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $11.76 | 2021 | |
| Aspira Women'S Health INC | $11.50 | 2021 | |
| Roche Diagnostics Corporation | $11.44 | 2021 | |
| Laborie Medical Technologies Corp. | $11.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clyde Meeks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.